描述:Advanced BioScience Laboratories, Inc (ABL) 是馬里蘭州的生物醫(yī)學(xué)研究公司,專責(zé)為生物醫(yī)學(xué)團(tuán)體提供資源開發(fā)和評估各種疫苗,治療和診斷傳染源。ABL是一個(gè)高度專業(yè)的合同研究組織(CRO ),具有與政府,商業(yè)和其他團(tuán)體合作的豐富經(jīng)驗(yàn)。
Advanced BioScience Laboratories, Inc (ABL) 是馬里蘭州的生物醫(yī)學(xué)研究公司,專責(zé)為生物醫(yī)學(xué)團(tuán)體提供資源開發(fā)和評估各種疫苗,治療和診斷傳染源。ABL是一個(gè)高度專業(yè)的合同研究組織(CRO ),具有與政府,商業(yè)和其他團(tuán)體合作的豐富經(jīng)驗(yàn)。ABL致力于預(yù)防艾滋病毒和傳染病的研究。ABL可以幫助各個(gè)領(lǐng)域的產(chǎn)品開發(fā),包括:基礎(chǔ)研究,疫苗或產(chǎn)品設(shè)計(jì),具有免疫調(diào)控的動(dòng)物模型,為*階段和第二階段的臨床試驗(yàn)生產(chǎn)cGMP生物制品以及許多其他服務(wù)。
ABL有著數(shù)以百計(jì)的出版物和在艾滋病毒和傳染病領(lǐng)域幾十年的研究經(jīng)驗(yàn)。
ABL有著悠久的歷史,為客戶提供免疫調(diào)控服務(wù)( ELISA方法,抗原表位的映射,免疫印跡,淋巴細(xì)胞的分離,流式細(xì)胞儀, elispot等) ,細(xì)胞庫,并擴(kuò)增和QC病毒(HIV, SIV, Vaccinia, CMV, HTLV, and FIV)和雜交瘤。
ABL還可以提供一系列廣泛的病毒學(xué)檢測方法的研究使用,如通過NASBA進(jìn)行RNA的病毒載量測試,抗病毒和病毒中和試驗(yàn),RIPA,抗原捕獲,檢測的RT和其它許多相關(guān)服務(wù)。
ABL還針對HIV,SIV和病毒學(xué)研究提供各種特殊產(chǎn)品,包括抗體,抗原,高免疫血清,病毒原液和抗原捕獲試劑盒。
Advanced BioScience Laboratories, Inc.報(bào)價(jià)表 | ||||
貨號(hào) | 品名 | 包裝 | 價(jià)格 | 品牌 |
5421 | HIV-1 p24 Antigen Capture Assay | 96t | 5310 | ABL |
2855 | Vaccinia Virus Titration In BSC-1 Cells | Each | 詢價(jià) | ABL |
2859 | Preparation of Vaccinia (From client provided seed) | Each | 詢價(jià) | ABL |
2910 | Native Human IL-2 (640 IU/mL) | 50mL | 2880 | ABL |
2911 | Native Human IL-2 (320 IU/mL) | 50mL | 1710 | ABL |
3231 | Direct Pellet (100x) | 1mL | 詢價(jià) | ABL |
3232 | Single Band in Sucrose Gradient (10,000x) | 1mL | 詢價(jià) | ABL |
3236 | HIV-1 IIIB (Prostak) | 1mL | 133740 | ABL |
3237 | HTLV-I | 1mL | 詢價(jià) | ABL |
3238 | SIV-1 | 1mL | 詢價(jià) | ABL |
4300 | Anti-p21E (Envelope) | 100ug | 3420 | ABL |
4301 | Anti-gp120 Env (Broadly Reactive) | 100ug | 3420 | ABL |
4302 | Anti-gp120 Env (C2 Domain, Reacts with Types M and O) | 100ug | 3420 | ABL |
4303 | Anti-gp120 Env (Type O) | 100ug | 3420 | ABL |
4304 | Anti-gp41 Env (Type O) | 100ug | 3420 | ABL |
4305 | Anti-Tat | 100ug | 3420 | ABL |
4310 | Anti-p24 Gag (Capsid Protein) | 100ug | 3420 | ABL |
4311 | Anti-gp120 (Conformational) | 100ug | 3420 | ABL |
4312 | Anti-gp41 Env | 100ug | 3420 | ABL |
4313 | Anti-p24 Gag | 100ug | 3420 | ABL |
4314 | Anti-p17 Gag (Cross Reacts with p55) | 100ug | 3420 | ABL |
4315 | Anti-p66/51 (RT) | 100ug | 3420 | ABL |
4317 | Anti-gp120 Env (aa307 to 320) | 100ug | 3420 | ABL |
4318 | Anti-gp120 Env (aa 35 to 108) | 100ug | 3420 | ABL |
4322 | Anti-gp32 Env (Weakly Nuetralizing) | 100ug | 3420 | ABL |
4323 | Anti-p27 Gag | 100ug | 3420 | ABL |
4324 | Anti-p27 Gag (Cross Reacts with HIV-1/2) | 100ug | 3420 | ABL |
4325 | Anti-p17 Gag | 100ug | 3420 | ABL |
4326 | Anti-gp120 Env | 100ug | 3420 | ABL |
4327 | Anti-gp120 Env (Neutralizing) | 100ug | 3420 | ABL |
5407 | Anti-p17 Gag from Rabbit | 1ml | 6210 | ABL |
5408 | Anti-gp120 Env (Clade E, Isolate 93TH976) from Rabbit | 1ml | 6210 | ABL |
5411 | Anti-gp120 Env (Clade C, Isolate 96ZM651) from Rabbit | 1ml | 6210 | ABL |
5412 | Anti-p24 Gag from Rabbit | 1ml | 4680 | ABL |
5413 | Anti-gp120 Env (mac251) from Rabbit | 1ml | 6210 | ABL |
5414 | Anti-gp120 Env (Clade B, Isolate IIIB) from Rabbit | 1ml | 6210 | ABL |
5415 | Anti-tat from Rabbit | 1ml | 6210 | ABL |
5416 | Anti-nef from Rabbit | 1ml | 6210 | ABL |
5417 | Anti-HTLV-I p24 Gag from Goat | 1ml | 4680 | ABL |
5418 | Anti-HTLV-I p24 Gag from Rabbit | 1ml | 4680 | ABL |
5419 | Anti-gp120 Env (Clade A, Isolate 92UG037) | 1ml | 6210 | ABL |
5420 | Anti-gp120 Env (Clade B, Isolate Ba-L) from Rabbit | 1ml | 6210 | ABL |
5422 | Anti-gp120 Env (Clade D, Isolate 57140) from Rabbit | 1ml | 6210 | ABL |
5423 | HIV-1 IIIB gp120 (Native) | 100ug | 16650 | ABL |
5424 | HIV-1 451 gp120 (Native) | 100ug | 15570 | ABL |
5425 | HIV-1 IIIB p24 | 100ug | 9090 | ABL |
5426 | HIV-1 IIIB gp140 (Native) | 100ug | 15570 | ABL |
5427 | HIV-1 451 gp140 (Native) | 100ug | 15570 | ABL |
5428 | SIV mac251 gp120 (Native) | 100ug | 15570 | ABL |
5429 | HIV-1 gp120 Antigen Capture Assay | 96t | 11160 | ABL |
5430 | SIV mac251 p27 (Native) | 100ug | 9360 | ABL |
5436 | SIV p27 Antigen Capture Assay | 96t | 6210 | ABL |
5441 | HIV-1 IIIB Biologically Active TAT (Recombinant) | 1 mg | 52848 | ABL |
5442 | HIV-1 IIIB Biologically Active TAT (Recombinant) | 100ug | 5292 | ABL |
5447 | Bulk HIV-1 p24 | 10x96t | 42750 | ABL |
5450 | Bulk SIV p27 | 10x96t | 53910 | ABL |